

"AI-powered clinical decision support for managing sight-threatening eye conditions"
Macusoft develops cloud-based artificial intelligence systems that detect, diagnose and manage preventable eye diseases. The company's clinical decision support tools analyse genomic, clinical and imaging data to predict optimal treatment plans for individual patients, addressing the high demand on ophthalmology departments and helping clinicians deliver more precise care. Health systems gain essential capacity through scalable, point-of-care technology that works in both hospital and remote settings. Patients benefit from evidence-based, individualised treatment for conditions like macular disease and diabetic retinopathy, reducing unnecessary sight loss caused by aging and diabetes.


8
Team Members
2017
Founded
Digital Health
Sector
Remote
Work Environment
A world where no one loses their sight to preventable eye disease because every clinician has instant access to intelligent, evidence-based decision support.
At Macusoft, our mission is to prevent unnecessary sight loss across the world by providing AI-powered clinical decision support systems that enable individualised, evidence-based treatment for chronic retinal diseases.